Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1993-10-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0006-3223
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
123-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8373934-Creatine Kinase,
pubmed-meshheading:8373934-Female,
pubmed-meshheading:8373934-Humans,
pubmed-meshheading:8373934-Iron,
pubmed-meshheading:8373934-Male,
pubmed-meshheading:8373934-Muscles,
pubmed-meshheading:8373934-Neuroleptic Malignant Syndrome,
pubmed-meshheading:8373934-Photometry,
pubmed-meshheading:8373934-Receptors, Dopamine
|
pubmed:articleTitle |
Serum iron levels in neuroleptic malignant syndrome.
|
pubmed:publicationType |
Letter
|